ACAD
Acadia Pharmaceuticals Inc. · Healthcare
Director Laura Brege sold $112K of Acadia Pharmaceuticals Inc.
Sold$111,906
$24.87Price
4,500Shares
−25%Stake
What ACAD did after the filing
- The stock from Thu, Jun 15 open, $24.15
- +21.1%
- S&P 500, same days
- +5.3%
Measured over 30 trading days, to the Jul 31 close.
Traded Mon, Jun 12. Filed Wed, Jun 14. Returns use the Jun 15 open and the Jul 31 close. Not investment advice.